Bicycle Therapeutics (BCYC) Earnings Date, Estimates & Call Transcripts $9.30 +0.22 (+2.42%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$9.16 -0.14 (-1.45%) As of 05/2/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bicycle Therapeutics Earnings Summary Latest Q1 Earnings DateMay. 1EstimatedConsensus EPS (May. 1) -$0.86 Actual EPS (May. 1) -$0.88 Missed By -$0.02 Actual Revenue (May. 1) $9.98MBicycle Therapeutics released Q1 2025 earnings on May 1, 2025, reporting an EPS of -$0.88, which missed analysts' consensus estimates of -$0.86 by $0.02. Quarterly revenue was reported to be $9.98 million, above the consensus estimate of $8.67 million. With a trailing EPS of -$3.14, Bicycle Therapeutics' earnings are expected to decrease next year, from ($3.06) to ($3.56) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q) Slide DeckSlide DeckFull Screen Slide DeckPowered by Get Bicycle Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bicycle Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBCYC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BCYC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Bicycle Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.99-$0.85-$0.90Q2 20253-$0.99-$0.86-$0.92Q3 20253-$0.99-$0.87-$0.94Q4 20253-$1.01-$0.89-$0.94 Bicycle Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025-$0.86-$0.88 -$0.02-$0.88$8.67M$9.98M2/25/2025Q4 2024-$0.85-$0.75+$0.10-$0.75$5.47M$3.70M10/31/2024Q3 2024-$0.78-$0.74+$0.04-$0.74$6.82M$2.68M8/6/2024Q2 2024-$1.10-$0.77+$0.33-$0.77$6.13M$9.36M5/2/2024Q1 2024-$1.25-$0.62+$0.63-$0.62$6.06M$19.53M2/20/2024Q4 2023-$1.23-$1.16+$0.07-$1.16$11.68M$5.33M11/2/2023Q3 2023-$1.06-$1.26 -$0.20-$1.26$21.29M$5.35M8/3/2023Q2 2023-$1.10-$1.41 -$0.31-$1.41$13.77M$11.40M5/4/2023Q1 2023-$1.06-$1.30 -$0.24-$1.30$4.34M$4.90M Bicycle Therapeutics Earnings - Frequently Asked Questions When did Bicycle Therapeutics announce their last quarterly earnings? Bicycle Therapeutics (NASDAQ:BCYC) last announced its quarterly earning data on Thursday, May 1, 2025. Learn more on BCYC's earnings history. Did Bicycle Therapeutics beat their earnings estimates last quarter? In the previous quarter, Bicycle Therapeutics (NASDAQ:BCYC) missed the analysts' consensus estimate of ($0.86) by $0.02 with a reported earnings per share (EPS) of ($0.88). Learn more on analysts' earnings estimate vs. BCYC's actual earnings. How much revenue does Bicycle Therapeutics generate each year? Bicycle Therapeutics (NASDAQ:BCYC) has a recorded annual revenue of $25.72 million. How much profit does Bicycle Therapeutics generate each year? Bicycle Therapeutics (NASDAQ:BCYC) has a recorded net income of -$180.66 million. BCYC has generated -$3.14 earnings per share over the last four quarters. What is Bicycle Therapeutics's EPS forecast for next year? Bicycle Therapeutics's earnings are expected to decrease from ($3.06) per share to ($3.56) per share in the next year. More Earnings Resources from MarketBeat Related Companies APLS Earnings Date IBRX Earnings Date BHVN Earnings Date KYMR Earnings Date CGON Earnings Date MTSR Earnings Date MIRM Earnings Date BHC Earnings Date BEAM Earnings Date NAMS Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:BCYC) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCYC Stock Free BCYC Stock Alerts